Introduction
The APO-1 /Fas (CD95) receptor was initially identified by agonistic mAb that induced apoptosis of certain tumor cells (1, 2) . Molecular cloning showed that APO-1 (3,4) was part of a family of type I cell surface receptors including tumor necrosis factor (TNF) receptors (5-7), CD27 (8) , CD30 (9), CD40 (10) and 4-1-BB (11) which share cysteine-rich extracellular domains. The ligands for these receptors are type II integral membrane proteins (12, 13) . Recent cloning of the APO-1 ligand demonstrated that it shares homologies with TNF (14) .
APO-1 is expressed on multiple cell types including thymocytes, myeloid cells, activated B and T cells, and fibroblasts (15) . It appears to play a critical role in the development of the immune system. Thus, mice homozygous for /pr(lymphoproliferation) that carry a retroviral insertion in the second mtron of the APO-1 gene show transcription of an abnormal APO-1 mRNA (16) . As a consequence activated lymphocytes, including T cells, express reduced numbers of APO-1 recep-APO-1/Fas receptor prevents APO-1/Fas-induced signaling (25) . More recently it was demonstrated that Fas-induced apoptosis is mediated via a ceramide-initiated Has signaling pathway (26) . Finally ligation of the APO-1 receptor leads to activation of a new class of cysteine proteases, including ILip-converting enzyme, which are homologous to the product of the Caenorrabditis elegans cell death gene ced-3 (27) .
The present paper demonstrates that binding of agonistic anti-APO-1 antibodies stimulates an early and transient increase of S-adenosylhomocysteine (AdoHcy), a potent inhibitor of S-adenosyl-dependent methylation reactions. Moreover, evidence is provided that AdoHcy functions as a physiological modulator enhancing APO-1 mediated cell killing in transfected L929 cells at least partially via the phospholipase A 2 (PU\ 2 ) pathway.
Methods
Cell culture and reagents L929 cells and L929-APO-1 cells, stably expressing human APO-1 cDNA (28) , and L929-APO-1 deletion mutants (L929 APO-1 A4 cells) lacking the C-terminal part of APO-1 were used as target cells for TNF and anti-APO-1, respectively. Anti-APO-1 mAb (mouse lgG3) has been described by Trauth et al. (1) and was used after purification by Protein A-affinity chromatography.
Preparation of APO-1 deletion mutants
The DNA encoding C-terminally truncated APO-1 was prepared by PCR. Oligonucleotides that were complementary to the single-stranded template and contained either Xho\ or Xba\ restriction sites were used for amplification. Plasmid pKEX-APO-1 (4) served as a template. The DNA fragments generated by PCR were digested with the restriction enzymes Xho\ and Xba\, purified by gel electrophoresis, and cloned into the pKEX2XR vector. The correct sequence was verified by double-strand DNA sequencing.
Transfection
L929 cells were transfected with an improved DNA/calcium phosphate co-precipitation technique (29) . A 1.07 Sst\\-Xba\ fragment of APO-1 cDNA was inserted into the eukaryotic expression vector pKEX2XR which contained a hygromycin resistance gene. Alternatively, a Xho\-Xba\ fragment of APO-1 cDNA corresponding to a truncation of the 27 C-terminal amino acids was inserted into pKEX2XR. The resulting plasmids, pKEX-APO-1 and pKEX-APO-1 A4 respectively, were purified on Quiagen columns (Diagen, Hilden, Germany). At 16 h before transfection cells were seeded at a density of 3X10 6 in 75 cm 2 flasks. Transfection was performed for 4 h in chloroquine (10 mM)-containing medium with a DNA precipitate containing 19 |ig pKEX-APO-1 or pKEX-APO-1 A4. After 24 h, cells were split 1:10 and selected for 2 weeks in the presence of 500 ng/ml hygromycin. Hygromycin-resistant clones were picked and screened for functional expression of APO-1 by flow cytometry and cytotoxicity assay
Cytotoxicity assay
The cytotoxic activity of TNF and anti-APO-1 was determined by a colorimetric assay (MTT test) (30) . L929 cells were seeded at a density of 1X10 4 cells/well in 96-well microtiter plates (flat bottomed) and incubated for 16 h in 0.2 ml culture medium. The supernatant was then removed and replaced by fresh medium containing serial dilutions of TNF and actinomycin D (1 ng/ml). Incubation was continued for 16 h followed by the addition of 10 nl of a MTT solution (5 mg/ml PBS). After another 4 h incubation, supernatants were removed followed by addition of 100 (il of a isopropanol/HCI solution (isopropanol and 1 N HCI; 24:1, v/v). The absorbance of each well was determined with an automated plate reader (SLT Easy Reader EAR 400 AT) at 550 nm. Survival was calculated as the percentage of the staining value of untreated cultures. Percent cytotoxicity is the difference between control (100%) and per cent survival.
TNF-induced arachidonic acid release
L929-APO-1-1, L929-APO-1-6 and L929 APO-1 A4 cells (2.5x10 6 ) were grown in 10 ml flasks in the presence of 10 |i.Ci [ 3 H]arachidonic acid (240 Ci/mmol; DuPont de Nemours, Dreieich, Germany) for about 18 h. Non-incorporated radioactive arachidonic acid was removed by three washes with prewarmed culture medium. Cells were then treated with anti-APO-1 (100 ng/ml) together with actinomycin D (1 (ig/ml) in 5 ml culture medium. Adenosine and D,i_-homocysteine as well as other compounds were tested in varying concentrations added 1 h before addition of anti-APO-1. Aliquots were removed at different times and centrifuged at 15,000 g Finally, the amount of free [3H]arachidonic acid was determined as shown in the following section. 
Identification and quantitation of

DNA fragmentation
DNA fragmentation was determined according to Wyllie and Morris (31) with minor modifications. Briefly, L929-APO-1-6 cells (5x10 6 cells/well) were cultured together with various concentrations of anti-APO-1 in the presence or absence of adenosine and D,L-homocysteine (1 mM each) in 6-well microtiter plates.
After 3 h cells were collected by centrifugation at 200 g for 10 min, washed with PBS and lysed in 1 ml hypotonic lysis buffer (10 mM Tris-HCI, pH 7.4, 1 mM EDTA, 100 mM NaCI) containing 1% SDS. The lysates were centrifuged at 13,000 g for 15 min. Supernatants were treated overnight at 37°C with proteinase K (0.2 mg/ml) and then extracted once with phenohchloroform (1:1, v/v). Extracted material was precipitated at -20°C with 65% ethanol, 200 mM sodium acetate. The precipitate was treated with RNase (1 mg/ml) and then subjected to agarose gel electrophoresis. After electrophoresis on 1.7% agarose slab gel, DNA was stained by ethidium bromide (5 ng/ml). In a separate experiment L929-APO-1-6 cells (5x10 6 /flask) were labeled with methyl-[ 3 H]thymidme (10 jj.Ci. 40-60 Ci/mmol; Amersham Buchler, Braunschweig, Germany) for 18 h, washed and then disrupted by one cycle of freezing at -70°C and thawing. DNA fragmentation was then quantitated as follows. Labeled high molecular weight unfragmentated genomic DNA was collected through glass filters (Pharmacia) and determined by scintillation counting. Results are expressed as percent of DNA fragmentation which was calculated as follows: % fragmentation = c.p.m. in control (unstimulated) group-c.p m. in stimulated groupx100/c.p m. in control (unstimulated) group.
Determination of cellular AdoHcy
L929 APO-1 clones and mutant cells were seeded in 6-well microtiter plates (2.5 x 10 6 cells/well) and permitted to grow for 16 h at 37°C. Cells were then incubated for 1 h with test substances and removed by scraping. They were resuspended in 2 ml PBS and the cell suspension was centrifuged at 7000 g for 20 s. The cell pellet was extracted with 150 u.l ice-cold 2.5% sulfosalicylic acid and the cell extract centrifuged for 5 min at 15,000 g. The supernatants were passed through Millipore filters (Millipore 0.22 ^M; Nikon Millipore, Kogyo, Japan) and then stored at -70°C and measured (20 nl) within 48 h. Analysis was performed by HPLC on a high speed BTC 2310 column (4x60 mm), using a chromatograph Model LC 3000 equipped with a spectrophotometer from Eppendorf Biotronic (Frankfurt, Germany). AdoHcy was eluted at increasing temperature and pressure at a flow rate of 0 18 ml/min and identified with ninhydrine at 570 nm. The elution buffer system A-F with a pH range from 2.85 to 10.60 was purchased from Eppendorf Biotronic and applied according to the suppliers recommendations.
Results
Cytotoxic activity induced by APO-1
To define events important for APO-1-mediated signaling expression vectors for intact and C-terminally truncated APO-1 were constructed and stably transfected into murine L929 cells. Several independent L929 clones expressing complete or mutated receptors were identified by flow cytometry. The fluorescence pattern of two transfectants is shown in Fig. 1 . One L929 clone expressing wild-type APO-1 receptors designated L929-APO-1-1 and one clone expressing truncated APO-1 (L929-APO-1 A4) were then assayed for anti-APO-1-induced apoptosis. Additionally, an independent clone, L-929-APO-1-6, previously described (28) was also used for further investigation. As shown in Fig. 2 , the clones L929-APO-1-1 and L929-APO-1-6 responded to anti-APO-1 in a dose-dependent manner. In the presence of the transcriptional inhibitor actinomycin D, half maximal response was obtained with 0.08 ng/ml anti-APO-1, and cells were completely killed with 1 ng/ml anti-APO-1. In contrast, L929-APO-1 A4 cells were found to be unresponsive to APO-1-mediated apoptosis. Expression of wild-type or truncated APO-1 receptor had no significant effect on the susceptibility to killing by TNF. Transfected cells were killed by the same concentration of TNF as the parental cell line (data not shown).
Anti-APO-1 stimulates AdoHcy formation
In unstimulated APO-1-transfected L929 cells (L929-AP0-1-1 and L929-APO-1-6 cells), the cellular content of AdoHcy was low ranging, from 12 to 20 pmol/10 6 cells (Fig. 3) . However, when these cells were treated with anti-APO-1 (1 ng/ ml), AdoHcy levels rose to 70 and 90 pmol/10 6 for L929-APO-1-1 and L929-APO-1-6 respectively, peaking at 30 min and then declining to control levels.
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•5 E Q. To examine whether the anti-APO-1-induced increase of AdoHcy was causally linked to APO-1-mediated apoptosis the deletion mutant L929-APO-1 A4 was tested to generate AdoHcy upon APO-1 stimulation As demonstrated in Fig. 3 this signaling deficient deletion mutant was unable to generate an increase of intracellular AdoHcy. This result suggested that AdoHcy may function as a mediator or modulator of APO-1-mediated apoptosis.
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A combination of adenosine and o,L-homocysteine potentiates anti-APO-1-induced apoptosis in L929-APO-1 cells
If AdoHcy formation is part of the APO-1 signaling pathway, then it should be possible to enhance apoptosis by increasing the intracellular AdoHcy level. To examine this possibility, APO-1/Fas-mediated cytotoxicity was investigated in the presence of adenosine and D.L-homocysteine. These compounds enter the cells and are converted into AdoHcy by the activity of the enzyme AdoHcy hydrolase. As shown in Fig. 4 , adenosine or D,L-homocysteine (1 mM each) alone slightly augmented anti-APO-1-induced cytotoxicity. However, when both compounds were added together they markedly potentiated anti-APO-1-induced apoptosis. Cytotoxicity of L929-APO-1-6 cells was still 90% at an anti-APO-1 concentration (0.016 \ig/m\) that had no effect when added alone. However, adenosine and D.L-homocysteine added either alone or in combination (without anti-APO-1) exhibited no cytotoxicity. This result clearly demonstrates that AdoHcy by itself is not a mediator but a modulator of anti-Apo-1-induced apoptosis.
Changes in intracellular AdoHcy and apoptosis in response to adenosine, D.L-homocysteine and anti-APO-1
HPLC analysis of intracellular AdoHcy was performed to confirm that the effects of adenosine and D,L-homocysteine on APO-1 signaling were due to an increase in AdoHcy. When , each) and anti-APO-1 (50 ng/ml) for 3 h followed by extraction with 150 nl icecold 2 5% sulfosalicylic acid Cellular extracts were centrifuged for 5 min at 15,000 g and AdoHcy was determined by HPLC. Cytotoxicity was determined as described in legend to Fig. 2 adenosine and D,L-homocysteine (1 mM each) were added alone, L929-AdoHcy concentration in APO-1-6 cells rose from 20 pmol/10 6 cells (normal levels) to 110 and 89 pmol/10 6 cells respectively (Table 1) . When adenosine and D,L-homocysteine (1 mM each) were added together, the AdoHcy level was markedly elevated to 1350 pmol/10 6 cells (see also Fig. 5 ). This level of AdoHcy alone was unable to induce cell death of L929 APO-1-6 cells. However, when adenosine and D,L-homocysteine were incubated in the presence of limiting amounts of anti-APO-1 (50 ng/ml), there was a marked potentiation of anti-APO-1 -induced apoptosis. Again this result supports the notion that AdoHcy is a modulator and not a mediator of APO-1/Fas-induced cytotoxicity. 
Effect of preloading cells with adenosine and D.L-homocysteine on anti-APO-1-induced apoptosis
Although there was a good correlation between elevation of AdoHcy and increase of anti-APO-1-induced apoptosis, adenosine and D,L-homocysteine could have acted via pathways that do not involve AdoHcy. Therefore, L929-APO-1-6 cells were preloaded with AdoHcy. Cells were pretreated with adenosine and D.L-homocysteine (1 mM each) to accumulate AdoHcy. After 1 h supernatants were removed and cells immediately incubated in the presence or absence of 9-fJ-Darabinofuranosyladenine (1 mM). This compound inactivates AdoHcy-hydrolase and, therefore, prevents degradation of AdoHcy (33) . After an additional 5 min anti-APO-1 was added. As shown in Fig. 6 , pretreatment with adenosine and D,Lhomocysteine (without 9-p-r>arabinofuranosyladenine) or with 9-[}-r>arabinofuranosyladenine alone enhanced anti-APO-1-induced cytotoxicity. However, maximum enhancement was achieved when L929-APO-1-6 cells were treated with a combination of adenosine, D.L-homocysteine and 9-(3-r>arabino-furanosyladenine. This result demonstrates that adenosine and homocysteine potentiate anti-APO-1-induced apoptosis by generating intracellular AdoHcy.
Possible mechanism of adenosine and homocysteine action
Anti-APO-1 may kill APO-1-6 cells as a result of nuclear damage, and adenosine and D,L-homocysteine may potentiate this process. To test this possibility two experiments were performed. In one L929-APO-1-6 were labeled with [ 3 H]thymidine and then exposed to different amounts of anti APO-1 in the presence or absence of adenosine and homocysteine (1 mM each). After 3 h cell lysates were centrifuged and DNA fragmentation was assessed by measuring the radioactivity in the supernatant. As shown in Fig. 7(A) in anti-APO-1-mediated apoptosis, two cultures of L929-APO-1-6 cells were prelabeled with [ 3 H]arachidonic acid and washed. Cells of one culture was directly extracted with methanohchloroform. Thin layer chromatography of the extract revealed that 97% of the radioactivity was phospholipid bound, whereas 3% represented free arachidonic acid. Cells of the second culture were exposed to anti-APO-1. As shown in Fig. 8 , anti-APO-1 (100 ng/ ml) stimulated release of [ 3 H]arachidonic acid into the supernatant in a time-dependent manner. After 18 h following stimulation 38% of the radioactivity incorporated into cells were released into the supernatant. Thin layer chromatography revealed that about 85% of the released radioactivity represented free arachidonic acid. To test whether anti-APO-1 -induced release of 3 H]thymidine for 18 h, washed and then exposed to anti APO-1 (0 5 and 0 1 |ig/ml) in the presence or absence of adenosine and D.L-homocysteine. DNA degradation was determined after a further 18 h. (B) L929-APO-1-6 cells were cultured together with anti-APO-1 (1 ng/ml) in the presence or absence of adenosine and D,i_-homocysteine (1 mM each) in 6-well titer plates (5X10 6 -cells/well). After 3 h, cells were collected by centrifugation, washed and lysed with lysis buffer (10 mM Tns-HCI, pH 7 4, 1 mM EDTA, 100 mM NaCI) containing 1% SDS Supernatants were deproteinated and precipitated at -20°C. After agarose electrophoresis on 1.7% agarose slab gels DNA was stained by ethidium bromide. Lanes 1-5 without Ado and Homo; lane 1, medium control, lane 2, 500 ng/ml anti-APO-1, lane 3, 100 ng/ml, lane 4, 50 ng/ml; lane 5, 10 ng/ml, lanes 6-10 with 1 mM Ado and 1 mM Homo: lane 7, 500 ng/ml anti-APO-1, lane 8, 100 ng/ml, lane 9, 50 ng/ml, lane 10, 10 ng/ml; lane 11, standard. absence of adenosine and D.L-homocysteine. As seen in Table  2 , adenosine and homocysteine (1 mM each) indeed enhanced the anti-APO-1-induced release of (Table 3) . These findings together suggest that the combination of adenosine and homocysteine potentiates anti-APO-1-induced release of arachidonic acid from phospholipids.
Discussion
The data in this paper provide evidence that AdoHcy, a potent inhibitor of S-adenosylmethionine (AdoMet)-dependent methylation reactions (34, 35) L-homocysteine were 1 mM each, of anti-Apo-1 0 1 ng/ml and of arachidonyl trifluoromethyl ketone 30 ng/ml. After an additional 15 h of incubation supernatants were removed and processed as described in the legend to Table 2 values represent means ± SD for three replicate cultures Cytotoxicity was evaluated by the MTT method.
involves degradation of phospholipids. Again it should be emphasized that accumulation of AdoHcy by itself does not lead to the release of arachidonic acid but enhances antiApo-induced release of arachidonic acid. This reinforces our conclusion that AdoHcy is not a mediator but a modulator of APO-1-induced apoptosis. AdoHcy exerts a variety of biological effects. It inhibits methylation of DNA, RNA, lipid and proteins (35) , and is a potent modulator of gene activation (36) , cellular differentiation, immunological responses (37) and antiviral activity (38) . Presently, it is unclear how AdoHcy enhances anti-APO-1-induced apoptosis. It is known that AdoHcy acts as potent inhibitor of AdoMet-dependent methylation reactions (34, 35) . Therefore, it is conceivable that AdoHcy potentiates anti-APO-1-induced cell killing by preventing methylation of target structures. These may include signal transduction proteins that mediate cytolytic processes such as the activation of PLA 2 or other regulatory proteins that control cytolytic pathways. These signal transduction proteins may include polypeptides that carry methylesters on carboxyl groups. Polypeptides that have these C-terminal modifications include ras proteins, many of their small G protein analogs, the 7-subunits of the large G proteins, some nuclear lamins or the catalytic subunit of protein phosphatase 2A (39) . It was shown that activation of APO-1 with anti-APO-1 antibodies caused induction of sphingomyelin hydrolysis and the generation of ceramide suggesting the involvement of the sphingomyelin pathway in anti-APO-1-induced apoptosis (40) . However, we found that accumulation of AdoHcy inhibits anti-APO-1-induced sphingomyelin hydrolysis and ceramide formation (data not shown). Thus, it is unlikely that AdoHcy acts as a mediator or positive regulator of the sphingomyelin pathway. It is more likely that AdoHcy is part of a sphingomyelin-mdependent pathway that triggers cell death.
It is interesting to note that TNF is unable to stimulate a transient increase of AdoHcy (40) , suggesting that APO-1 and TNF receptor-mediated cytotoxic signal pathways are different. Indeed it was demonstrated that TNF-mduced cytotoxicity is mediated by reactive oxygen intermediates generated during mitochondrial respiration, whereas no such mediators are involved in APO-1-mediated apoptosis (28) . Yet, both TNF and anti-APO-1 induce the release of arachidonic acid in L929-APO-1 cells, suggesting that both pathways may converge in a pathway that is associated with the activation of PLA2 in these cells. This conclusion is supported by results shown in this paper and by recent observations (unpublished results) that both the APO-1-and the TNFinduced release of arachidonic acid is enhanced by AdoHcy and that both modulated processes are inhibited by the PLA 2 inhibitor arachidonyl trifluoromethyl ketone.
Taken together, the results described in this report provide a basis to further delineate the signal transduction pathway that links triggering of the APO-1 receptor to cell destruction.
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